P-glycoprotein (P-gp)-mediated efflux limits intestinal absorption of the Hsp90 inhibitor SNX-2112 in rats
about
Elucidating the in vivo fate of nanocrystals using a physiologically based pharmacokinetic model: a case study with the anticancer agent SNX-2112.Pharmacokinetic characterization of anhuienoside C and its deglycosylated metabolites in rats.Metabolite profiling of anhuienoside C by rat intestinal bacteria using the LC-MS metabolomic approach.
P2860
P-glycoprotein (P-gp)-mediated efflux limits intestinal absorption of the Hsp90 inhibitor SNX-2112 in rats
description
im August 2014 veröffentlichter wissenschaftlicher Artikel
@de
наукова стаття, опублікована в серпні 2014
@uk
name
P-glycoprotein (P-gp)-mediated ...... p90 inhibitor SNX-2112 in rats
@en
type
label
P-glycoprotein (P-gp)-mediated ...... p90 inhibitor SNX-2112 in rats
@en
prefLabel
P-glycoprotein (P-gp)-mediated ...... p90 inhibitor SNX-2112 in rats
@en
P2093
P2860
P1433
P1476
P-glycoprotein (P-gp)-mediated ...... p90 inhibitor SNX-2112 in rats
@en
P2093
Baojian Wu
Hongming Liu
Xingwang Zhang
Zhufeng Wu
P2860
P356
10.3109/00498254.2014.891781
P407
P577
2014-08-01T00:00:00Z